imatinib mesylate has been researched along with Carcinosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, RD; Birrer, MJ; Boggess, JF; Darcy, KM; Elias, KM; Hoffman, JS; Huh, WK; Long, HJ; O'Malley, DM; Sill, MW | 1 |
| She, R; Szakacs, J | 1 |
1 trial(s) available for imatinib mesylate and Carcinosarcoma
| Article | Year |
|---|---|
Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Carcinosarcoma; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Treatment Outcome; Uterine Neoplasms | 2010 |
1 other study(ies) available for imatinib mesylate and Carcinosarcoma
| Article | Year |
|---|---|
Carcinosarcoma of the liver: a case report and review of the literature.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Carcinosarcoma; Diagnosis, Differential; Fatal Outcome; Female; Hepatorenal Syndrome; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Sarcoma | 2005 |